Measuring the Changes of the Intraocular Pressure After Corneal Laser Refractive Surgery Using Different Techniques

April 17, 2026 updated by: Dina Tadros, Tanta University
To evaluate the changes that occur in the intraocular pressure after corneal refractive surgery either PRK , LASIK and femtosecond laser by using Corvis CT results and applanation tonometer

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

This study will be prospective study. 50 Patients who will undergo refractive surgery referred from the out-patient clinic of Tanta University hospital between December 2025 and December 2026 will be included in the study . The patient will be randomly selected to do either LASIK, PRK or femtosecond laser LASIK

Patients who will undergo refractive surgery either PRK, LASIK or femtosecond laser with age between 19 and 35 years old , Myopia range from (-2.00 to -6.00 Diopter) and to maintain stability of the data we will use only the right eye of each patient will be included on the study

Kertoconus, Corneal scarring, Previous corneal infections, Minimum corneal thickness at the thinnest location less than 400 µm, History of uveitis or ocular allergy and Pre-existing glaucoma will be excluded from the study.

Age, sex, uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), manifest and cycloplegic refraction, Slit lamp biomicroscopy, fundus examination , Central corneal thickness (CCT) and average Keratometer (K) data will be collected

Intraocular pressure will be measured by by two methods : Corvis CT and applanation tonometer for each patient and will be recorded, all the data will be collected before the refractive surgery and one month after refractive surgery

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Tanta, Egypt, 31515
        • Tanta Univeristy Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age between 19 and 35 years old
  • Myopia range from (-2.00 to -6.00 Diopter) .

Exclusion Criteria:

  • Kertoconus.
  • Corneal scarring.
  • Previous corneal infections.
  • Minimum corneal thickness at the thinnest location less than 400 µm.
  • History of uveitis or ocular allergy.
  • Pre-existing glaucoma.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Measuring intraocular pressure by using different techniques
Measuring intraocular pressure by different methods and compare the results

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measuring intraocular pressure
Time Frame: -The data collected will be before that laser surgery and one month after surgery
Intraocular pressure will be measured by in mmHg and by two methods : Corvis CT and applanation tonometer for each patient and will be recorded
-The data collected will be before that laser surgery and one month after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • 1. Bailey MD, Zadnik K (2007) Outcomes of LASIK for myopia with FDA-approved lasers. Cornea 26(3):246-254 2. Sridhar MS, Rao SK, Vajpayee RB, Aasuri MK, Hannush S, Sinha R (2002) Complications of laser-in situ-ker- atomileusis. Indian J Ophthalmol 50(4):265-282 3. Mohammadi SF, Nabovati P, Mirzajani A, Ashrafi E, Vakilian B (2015) Risk factors of regression and under- correction in photorefractive keratectomy: a case-control study. Int J Ophthalmol 18;8(5): 933-937 4. Diakonis VF, Kankariya VP, Kymionis GD, Kounis G, Kontadakis G, Gkenos E, Grentzelos MA, Hajithanasis G, Yoo SH, Pallikaris IG (2014) Long term followup of pho- torefractive keratectomy with adjuvant use of mitomycin C. J Ophthalmol 2014:821920 5- dos Santos AM, Torricelli AA, Marino GK, Garcia R, Netto MV, Bechara SJ, Wilson SE. Femtosecond Laser-Assisted LASIK Flap Complications. J Refract Surg. 2016 Jan;32(1):52-9 6- Wang LK, Tian L and Zheng YP. Determining in vivo elasticity and viscosity with dynamic Scheimpflug imaging analysis in keratoconic and healthy eyes. J Biophotonics, 2016; 9: 454-463. 7.ConsejoA,MelcerT,RozemaJJ.Introductiontomachinelearningforophthalmologists.SeminOphthalmol.2019;34(1):19 _41.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 20, 2026

Primary Completion (Estimated)

October 20, 2026

Study Completion (Estimated)

January 16, 2027

Study Registration Dates

First Submitted

January 17, 2026

First Submitted That Met QC Criteria

April 17, 2026

First Posted (Actual)

April 24, 2026

Study Record Updates

Last Update Posted (Actual)

April 24, 2026

Last Update Submitted That Met QC Criteria

April 17, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 36264PR1310100/12/25

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Results after statistical analysis will be shared in the manuscript

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intraocular Pressure

Clinical Trials on Corvis machine

Subscribe